欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2173/002
药品名称Rivaroxaban STADA
活性成分
    • RIVAROXABAN 20.0 mg
剂型Capsule, hard
上市许可持有人Stada Arzneimittel GmbH, Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Rivaroxaban AL 20 mg Hartkapseln
    • Finland (FI)
    • Denmark (DK)
      Rivaroxaban STADA
    • Latvia (LV)
    • Belgium (BE)
    • Lithuania (LT)
      -
    • Netherlands (NL)
    • Estonia (EE)
      Rivaroxaban Stada
    • Luxembourg (LU)
    • Romania (RO)
      Rivaroxaban STADA 20 mg capsule
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Norway (NO)
许可日期2022/11/24
最近更新日期2024/07/24
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase